# Independent review of the eleven-configuration checkpoint

**Reviewer:** portfolio-research agent. **Scope:** `research/DISCOVERY_CHECKPOINT.md`, `README.md`, and `research/EXPERIMENT_LEDGER.md`, compared with existing saved evidence only. No strategy was replayed, model variant fitted, new numerical test added, or protected-period input opened.

**Final disposition: approved as a private discovery checkpoint, with requested reporting corrections applied and independently read back.** The numerical comparison, research decision, and scope boundaries are supported. No candidate change or additional experiment was required.

## Confirmed

- Every numerical row in the checkpoint table matches the corresponding `evidence/discovery_C01_001/summary.json` through `discovery_C11_001/summary.json` at the displayed precision. Each run has exit 0, 20 passing recorded workflow checks, the same score slice `[253,2015)`, and all recorded path-feasibility flags true.
- C06 is the provisional development leader at net Sharpe 0.762944. C11 is below C02 on both net and gross Sharpe, with higher full fees. The reported first-wave paired-bootstrap intervals match `evidence/comparison_wave1_001/REPORT.md`; their conditional, search-uncorrected interpretation is explicit.
- C01 and C02 each completed 28 fresh-process smoke workflows: one completed baseline and 27 passing comparison scenarios. C11's four synthetic workflows and 40 checks, twelve exact protected numerical comparisons, and 0.997914 forecast/truth correlation agree with the saved successful workflow. Artificial-fixture performance is properly separated from supplied-market economics.
- Eleven scored complete configurations are recorded, with slot 12 unassigned. Historical admission entries are preserved as such; the latest ledger section clearly records checkpoint closure and the C11 negative finding.
- No validation shortlist or final winner is declared frozen. Validation and audit remain economically unopened, and actual long-history, complete finalist-specific causal/runtime, and clean final-package gates remain incomplete. The source hygiene reads are not misrepresented as economic inspection of protected data.
- The README identifies the default `strategy.py` as the C01 development benchmark rather than a selected hand-in. AI attribution, source preservation, interrupted/negative evidence, shared-host timing limits, and the absence of a proven durable edge are clear.

## Corrections requested and applied before publication

1. In the GLS/factor finding, replace **“It reduced common exposure and risk”** with **“It reduced realized volatility and net market beta.”** The latter describes directly recorded quantities. A broader claim about residual common-factor exposure is not established by the cited saved summary.
2. In the numerical-verification paragraph, replace **“Their custom numerical components were specified and checked before their implementations”** with a statement that **verification plans and executable tests were written before implementation, expected missing-module red runs were preserved, and successful component checks followed implementation.** This preserves the exact user-mandated order without implying a component passed before it existed.

Optional precision: describe the C01/C02 causality record as 28 completed fresh-process workflows each, including one baseline and 27 passing comparison scenarios. The existing wording is understandable, but this matches the saved status categories exactly.

Readback confirmed that the checkpoint now states **“reduced realized volatility and net market beta,”** correctly places verification plans and executable tests before implementation with expected-red and subsequent passing checks preserved, and identifies the C01/C02 record as 28 fresh processes each with one baseline and 27 comparison scenarios. All requested edits, including the optional precision, are applied.

This review supports publication as a private discovery checkpoint. It does not approve finalist nomination, protected evaluation, a final employer submission, or another experiment. This review and `reviews/interactions_independent_review.md` are stable for the lead's commit; no further edits are pending from this reviewer.
